Global Medical REIT Statistics
Share Statistics
Global Medical REIT has 66.80M shares outstanding. The number of shares has increased by 0.03% in one year.
Shares Outstanding | 66.80M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | n/a |
Shares Floating | 63.03M |
Failed to Deliver (FTD) Shares | 12 |
FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 1.20M, so 1.8% of the outstanding shares have been sold short.
Short Interest | 1.20M |
Short % of Shares Out | 1.8% |
Short % of Float | 1.91% |
Short Ratio (days to cover) | 4.31 |
Valuation Ratios
The PE ratio is 35.3 and the forward PE ratio is 109.88.
PE Ratio | 35.3 |
Forward PE | 109.88 |
PS Ratio | 5.16 |
Forward PS | 3.8 |
PB Ratio | 1.25 |
P/FCF Ratio | 12.46 |
PEG Ratio | n/a |
Enterprise Valuation
Global Medical REIT Inc. has an Enterprise Value (EV) of 1.34B.
EV / Earnings | 65.22 |
EV / Sales | 9.54 |
EV / EBITDA | 12.04 |
EV / EBIT | 35.44 |
EV / FCF | 23.02 |
Financial Position
The company has a current ratio of 2.25, with a Debt / Equity ratio of 1.05.
Current Ratio | 2.25 |
Quick Ratio | 2.25 |
Debt / Equity | 1.05 |
Total Debt / Capitalization | 51.16 |
Cash Flow / Debt | 0.11 |
Interest Coverage | 1.23 |
Financial Efficiency
Return on equity (ROE) is 0.04% and return on capital (ROIC) is 3.1%.
Return on Equity (ROE) | 0.04% |
Return on Assets (ROA) | 0.02% |
Return on Capital (ROIC) | 3.1% |
Revenue Per Employee | 5.42M |
Profits Per Employee | 792.77K |
Employee Count | 26 |
Asset Turnover | 0.11 |
Inventory Turnover | 0 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -23.69% in the last 52 weeks. The beta is 1.28, so Global Medical REIT 's price volatility has been higher than the market average.
Beta | 1.28 |
52-Week Price Change | -23.69% |
50-Day Moving Average | 9 |
200-Day Moving Average | 9.03 |
Relative Strength Index (RSI) | 32.4 |
Average Volume (20 Days) | 401.49K |
Income Statement
In the last 12 months, Global Medical REIT had revenue of $140.93M and earned $20.61M in profits. Earnings per share was $0.23.
Revenue | 140.93M |
Gross Profit | 54.72M |
Operating Income | 37.94M |
Net Income | 20.61M |
EBITDA | 111.64M |
EBIT | 37.94M |
Earnings Per Share (EPS) | 0.23 |
Balance Sheet
The company has $1.28M in cash and $618.91M in debt, giving a net cash position of -$617.63M.
Cash & Cash Equivalents | 1.28M |
Total Debt | 618.91M |
Net Cash | -617.63M |
Retained Earnings | -238.98M |
Total Assets | 1.24B |
Working Capital | -635.25M |
Cash Flow
In the last 12 months, operating cash flow was $68.44M and capital expenditures -$10.05M, giving a free cash flow of $58.39M.
Operating Cash Flow | 68.44M |
Capital Expenditures | -10.05M |
Free Cash Flow | 58.39M |
FCF Per Share | 0.89 |
Margins
Gross margin is 38.82%, with operating and profit margins of 26.92% and 14.63%.
Gross Margin | 38.82% |
Operating Margin | 26.92% |
Pretax Margin | 15.42% |
Profit Margin | 14.63% |
EBITDA Margin | 79.21% |
EBIT Margin | 26.92% |
FCF Margin | 41.43% |
Dividends & Yields
GMRE pays an annual dividend of $0.84, which amounts to a dividend yield of 9.91%.
Dividend Per Share | $0.84 |
Dividend Yield | 9.91% |
Dividend Growth (YoY) | 0% |
Payout Ratio | -4200% |
Earnings Yield | 2.73% |
FCF Yield | 10.36% |
Analyst Forecast
The average price target for GMRE is $10.88, which is 28.9% higher than the current price. The consensus rating is "Buy".
Price Target | $10.88 |
Price Target Difference | 28.9% |
Analyst Consensus | Buy |
Analyst Count | 2 |
Scores
Altman Z-Score | -0.19 |
Piotroski F-Score | 7 |